Skip to main content
. 2023 Feb 15;13(2):654–668.

Figure 3.

Figure 3

Kaplan-Meier analyses of overall survival. A. All patients. B. Patients with or without macrovascular invasion (MVI). C. Patients with a CRAFITY score of 2 vs score = 0 or 1. D. Patients with or without combination therapy. E. Patients with or without disease control. F. Patients in different groups according to the combination of CRAFITY score and AFP response (CRAFITY/AFPr). Survival is presented as median (95% confidence interval). AFP, α-fetoprotein; CRAFITY, C-reactive protein and α-fetoprotein in immunotherapy; mOS, median overall survival.